Ligand-activated site-specific recombination in mice.

AUTOR(ES)

Feil, R

RESUMO

Current mouse gene targeting technology is unable to introduce somatic mutations at a chosen time and/or in a given tissue. We report here that conditional site-specific recombination can be achieved in mice using a new version of the Cre/lox system. The Cre recombinase has been fused to a mutated ligand-binding domain of the human estrogen receptor (ER) resulting in a tamoxifen-dependent Cre recombinase, Cre-ERT, which is activated by tamoxifen, but not by estradiol. Transgenic mice were generated expressing Cre-ERT under the control of a cytomegalovirus promoter. We show that excision of a chromosomally integrated gene flanked by loxP sites can be induced by administration of tamoxifen to these transgenic mice, whereas no excision could be detected in untreated animals. This conditional site-specific recombination system should allow the analysis of knockout phenotypes that cannot be addressed by conventional gene targeting.

Documentos Relacionados

• Cre-mediated somatic site-specific recombination in mice.
• Tissue- and site-specific DNA recombination in transgenic mice.
• Ligand-regulated site-specific recombination.
• Targeted oncogene activation by site-specific recombination in transgenic mice.
• Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice.